We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What Is the Difference between ARBs and ACE Inhibitors?

Tricia Christensen
By
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors differ the most in the way that they affect the renin-angiotensin-aldosterone (RAA) system, which helps to control blood pressure. Other slight differences between ARBs and ACE inhibitors can include a decreased risk of certain side effects, especially persistent cough with ARBs. Some studies have suggested that women who use ARBs after a heart attack have higher survival rates than women who use ACE inhibitors. In most other ways, these two classes of drugs are very similar.

ARBs and ACE inhibitors affect the RAA system in slightly different ways that both relate to angiotensin II. This is a powerful chemical that signals blood vessels to constrict, and it can contribute to hypertension. ARBs, such as candesartan, losartan, and irbesartan, prevent angiotensin II from connecting with receptors on small arteries. This means that the blood vessels don’t narrow, and blood pressure is reduced.

The action of ACE inhibitors is very different, though the overall effect is similar. Medications like benzapril, enalapril, and lisinopril prevent the conversion of angiotensin I into angiotensin II. The absence of this chemical means the blood vessels get few chemical messages to constrict, and blood pressure normalizes.

Another difference between the two may be the degree to which certain side effects are experienced. Patients who have trouble tolerating ACE inhibitors are often switched to an ARB. This is mainly due to the symptoms of difficult coughing that ACE inhibitors commonly cause. An ARB can have this side effect, too, but not as often, and many patients are made more comfortable if they switch to one.

Moreover, preliminary research suggests that ARBs may be a better choice for women who have experienced a heart attack. Some studies have evaluated mortality rates in women who take these medications after a heart attack. The evidence suggests that ARBs appear to improve life expectancy, but only for women. There needs to be more study in this area to confirm these results.

Despite some differences, ARBs and ACE inhibitors are similar in many ways. They’re both recommended to regulate high blood pressure, lengthen survival after a heart attack, and slow the progression of kidney failure caused by diabetes. Drugs from these classes may additionally protect against stroke. It's also suggested that these medications may help prevent high cholesterol.

These drugs also have comparable side effects, including headache, dizziness, and cough. Additional adverse reactions include diarrhea, rash, and allergy. Both classes of drugs can cause serious birth defects and may interact with the same medications, like lithium.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Tricia Christensen
By Tricia Christensen
With a Literature degree from Sonoma State University and years of experience as a The Health Board contributor, Tricia Christensen is based in Northern California and brings a wealth of knowledge and passion to her writing. Her wide-ranging interests include reading, writing, medicine, art, film, history, politics, ethics, and religion, all of which she incorporates into her informative articles. Tricia is currently working on her first novel.
Discussion Comments
Tricia Christensen
Tricia Christensen
With a Literature degree from Sonoma State University and years of experience as a The Health Board contributor, Tricia...
Learn more
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.